The company currently estimates the full-year 2024 gross profit margin to be in the 65%-67% range. In addition, the company expects 2024 operating expenses in the range of $125M-$128M. The company is also anticipating full-year 2024 non-cash expenses in the range of $22M-$25.0M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on RXST:
- RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance
- RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
- RxSight price target raised by $7 at BTIG, here’s why
- RxSight price target raised to $43 from $36 at BTIG
- Microsoft initiated, Hertz downgraded: Wall Street’s top analyst calls
